drugset / Trial / NCT01061203

Grazax Asthma Prevention

NCT01061203

Phase 3 Completed 812 enrolled ALK-Abelló A/S
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Investigation of the effect of Grazax (grass tablet) on asthma prevention in children with grass pollen allergy

Timeline

Start
2010-01
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Grazax Other / unclassified 75 unknown Other

Indications